4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents
US6693114B2 · kind B2 · utility
0Cited by
11References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 20, 2002 |
| Grant date | Feb 17, 2004 |
| Priority date | — |
| Expiry date | May 20, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound of formula III: or a pharmaceutically acceptable salt thereof wherein, the variables are as in the specification is provided. The compounds are particularly effective in the treatment or prevention of herpes viruses.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.